Drug Shortage Report for OXYTOCIN INJECTION, USP

Last updated on 2019-11-28 History
Report ID 95462
Drug Identification Number 02139561
Brand name OXYTOCIN INJECTION
Common or Proper name Oxytocin Injection
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) OXYTOCIN
Strength(s) 10UNIT
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS
Packaging size 10mL
ATC code H01BB
ATC description POSTERIOR PITUITARY LOBE HORMONES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2019-10-04
Estimated end date Unknown
Actual end date 2019-11-08
Shortage status Resolved
Updated date 2019-11-28
Company comments 10mL allocations have been reduced to 50% of historical 10mL demand. Customers with no historical 10mL demand will receive a limited allocation of 10mL vials to support the shortage of 1mL vials. Please note that this will be a one time allocation. The amount allocated will need to last customers until the end of November, there will be no more stock available of either size once you have purchased your one time allocation.
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2019-11-28 French Compare
v4 2019-11-28 English Compare
v3 2019-10-05 English Compare
v2 2019-10-04 French Compare
v1 2019-10-04 English Compare

Showing 1 to 5 of 5